xeneticbio.com - XBIO Operating profit EBITDA

Public company logo of xeneticbio.com (XBIO)

Xenetic Biosciences (XBIO) develops targeted drugs against dangerous tumors, leveraging patents and licensing agreements with pharmaceutical behemoths. An innovative method of disrupting the cancer's protective barrier using enzymes exponentially enhances the impact of chemotherapy. Royalties support the company's stability, offsetting the risks associated with early clinical trials. Data from the GURU.Markets terminal provides a fixed EBITDA level, where the value is recorded at 0.00.

XBIO - Xenetic Biosciences, Inc. Operating profit EBITDA over the range 11/23/2025 - 11/16/2026

Xenetic Biosciences, Inc. (XBIO) - metric breakdowns and financial figures

- current quotes and average value forecast:
Analysis of all company metrics:xeneticbio.com - XBIO
Flagship merchandise of xeneticbio.com

Absolute operating profit measures a business's ability to generate cash flow before depreciation and interest, which is critical for assessing solvency during a period of high interest rates. The current EBITDA_Co level on this chart is 0.00, reflecting the efficiency of the Xenetic Biosciences (XBIO) scientific platform and its clinic partnerships in sustaining oncology drug development amid expensive financing.

Who Xenetic Biosciences competes with

Operating profit EBITDA beigene.com ONC|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Corp - Income before deduction of interest, taxes and amortization|URGN (UroGen Pharma Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Therapeutics Inc. BCAX|Profit before payment of interest, taxes and amortization Personalis, Inc. (PSNL)|ERAS - Profit before interest, taxes and amortization|Operating profit EBITDA DCTH (delcath.com)|Operating profit before depreciation charges Y-mAbs Corp|AURA - Profit before payment of interest, taxes and amortization|CADL (candeltx.com) - Operating profit before amortization|ARAY (accuray.com) - Operating profit before deduction of amortization|SELLAS Life Sciences Group Inc. (SLS) - Operating profit EBITDA|ACTU (Actuate Therapeutics Inc.) - Operating profit EBITDA|Operating profit EBITDA Citius Oncology Inc|Operating profit EBITDA HURA|TARA (Protara Therapeutics) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA FATE (Fate Therapeutics)|Operating income before deduction of amortization Aadi Bioscience Inc (WHWK)|TScan Therapeutics, Inc. - Operating profit EBITDA|CSBR (Champions Oncology, Inc.) - Operating profit before amortization|XBIT (XBiotech USA) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization CEL-SCI Corp (CVM)|OSTX (OS Therapies Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization Radiopharm Theranostics (RADX)|Operating profit before deduction of amortization ARTV (Artiva Biotherapeutics, Inc.)|ANL - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Veru Inc. VERU|Income before deduction of interest, taxes and amortization TPST|XLO: Operating profit before deduction of amortization|Operating income before deduction of amortization Renovaro RENB|MURA (muraloncology.com) - Operating profit before deduction of amortization|Kairos Pharma Inc - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization OKUR|Profit before interest, taxes and amortization CytoMed Therapeutics Limited GDTC|Operating profit EBITDA CRIS|Operating profit EBITDA Apollomics Inc. (APLM)|Operating profit EBITDA THAR (Tharimmune Corp)|Operating income before deduction of amortization Advanced Biomed Inc (ADVB)|Genprex Inc - Operating profit EBITDA|CLDI - Operating profit EBITDA|Sunshine Biopharma Inc. (SBFM) - Profit before payment of interest, taxes and amortization|SLRX: Company profit before taxes, interest and amortization|PPBT (Purple Biotech Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization American Oncology Network, Inc. AONC|Operating profit EBITDA BGNE|Operating income before deduction of amortization Checkpoint Therapeutics|Elevation Oncology, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA iCAD, Inc. ICAD|Ikena Oncology, Inc. - Operating profit EBITDA|NTBL - Operating profit EBITDA|VIRX (Viracta Therapeutics) - Operating profit before deduction of amortization|MorphoSys AG - Income before deduction of interest, taxes and amortization|NAYA (NAYA Biosciences Corp) - Operating profit EBITDA|Operating profit EBITDA Ascentage Pharma Group International